跳至主要内容
临床试验/NCT00921297
NCT00921297已完成不适用

Therapeutic Effects of Cataract Removal in Alzheimer's Disease

University Hospitals Cleveland Medical Center4 个研究点 分布在 1 个国家目标入组 122 人开始时间: 2009年6月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
122
试验地点
4
主要终点
Visual acuity, spatial contrast sensitivity, visual perception and cognition

研究概览

简要总结

Two very common aging-related diseases in older adults are Alzheimer's disease (AD) and cataracts. In elderly adults, these two diseases frequently occur in the same person. Although a cure for AD is currently unavailable, cataracts can be effectively treated with surgery in most people. The removal of cataracts has documented benefits for visual performance and for reducing accidents and falls. However, it has been the experience of the ophthalmologists, and others in the field, that patients, caregivers, and primary care doctors are reluctant to proceed with cataract surgery once an individual is given the diagnosis of AD. It is thought that cataract surgery will not improve the AD patient's quality of life, vision, and cognition. The investigators have designed this study to determine whether or not this is true.

详细描述

In this project, we propose to test the following clinical hypothesis, while addressing the primary and two secondary Specific Aims:

Hypothesis: Cataract removal produces measurable benefits in vision, perception, independent function, and quality of life in patients with co-morbid Alzheimer's disease.

Primary Specific Aim: To determine the effects of cataract removal on visual acuity, spatial contrast sensitivity, vision dependent functions, visual information processing, and quality of life in patients with Alzheimer's disease.

Secondary Specific Aims.

  1. To delineate the baseline characteristics of those patients who benefit most from the surgical intervention.
  2. To assess the thickness of the retinal nerve fiber layer (RNFL) with optical coherence tomography (OCT) in large samples of AD patients classified with mild or moderate dementia to determine if the thickness of the RNFL is associated with dementia severity, visual performance measures, and other patient characteristics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
50 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 50 and older
  • clinical diagnosis of possible/probable Alzheimer's disease, or other type of dementia, mild (CDR-1), moderate (CDR-2), or severe (CDR-3)
  • at least 1 visually significant cataract
  • no ocular pathology
  • psychotropic drug must be with stable dosage for 30 days

排除标准

  • history of cataract removal
  • history of visually significant retinal, or optic nerve abnormalities
  • informed consent cannot be obtained from either subject or their research partner
  • subject shows evidence (in preoperative testing) of unstable cardiac or pulmonary function
  • history of uncontrolled diabetes or hypertension
  • history of stroke in areas known to affect cognition
  • life expectancy of less than 1 year
  • Down's Syndrome

研究组 & 干预措施

Immediate Cataract Surgery

Active Comparator

Subjects randomly selected into the Immediate Surgery group will have their cataract surgery scheduled one month from the time their initial study visits are completed. The subjects will be followed monthly for a period of 6 months for surgical and non-surgical adverse events. At the 6-month point, subjects will receive a final comprehensive eye exam and neuropsychological testing. The research partners will complete final activities of daily living and resource utilization questionnaires.

干预措施: Immediate Cataract Surgery (Procedure)

Delayed Cataract Surgery

No Intervention

Subjects selected into the Delayed Surgery group will be asked to delay their surgery for 6 months after their initial study visits. At 6 months, this group will also undergo the same testing as the Surgery Group.

结局指标

主要结局

Visual acuity, spatial contrast sensitivity, visual perception and cognition

时间窗: Baseline and Month 6

次要结局

  • Independent function(Baseline and Month 6)
  • Quality of Life(Baseline and Month 6)
  • Retinal Nerve Fiber Layer(Baseline, Months 2,4, & 6)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Grover C. Gilmore, PhD.

Principal Investigator

Case Western Reserve University

研究点 (4)

Loading locations...

相似试验